{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "18e51bbc-42c8-4394-8522-5dd1cbbb9229",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, re, time, requests,json\n",
    "from bs4 import BeautifulSoup\n",
    "from openai import OpenAI\n",
    "from datetime import datetime\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9f3442c3-8a65-4fe4-92da-01e8acedc295",
   "metadata": {},
   "source": [
    "# 爬取"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0cb18281-87a1-439b-9dec-1f5647abb602",
   "metadata": {},
   "source": [
    "## 爬取menet.com"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "ec91ffb1-359b-4d0c-956d-86db149f7df0",
   "metadata": {},
   "outputs": [],
   "source": [
    "host = 'https://www.menet.com.cn/news'\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "e516179a-ece2-4966-b603-a2c4ce62c5f0",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_list(host):\n",
    "    response = requests.post(host)\n",
    "    soup = BeautifulSoup(response.text, 'html.parser')\n",
    "    news_list = [_ for _ in soup.find_all('h3') if \"登录\" not in _.text]\n",
    "    return soup, news_list\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "171b09a7-7f06-4166-bd82-b4868325732f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_info(item, host ='https://www.menet.com.cn'):\n",
    "    link, title, date = host + item.a['href'], item.text,  item.a['href'].split('/')[3][:8]\n",
    "    return {\n",
    "    \"title\": title,\n",
    "    'url': link,\n",
    "    'date':date\n",
    "}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "fd59a248-54c1-4ee2-af10-de46462bba5a",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup, news_list = get_list(host)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "229e9ad2-1209-41b7-8731-f99896ed87dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "result_menet = list(map(get_info, news_list))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0a5e46b7-2415-4a58-8170-3d174b1a1640",
   "metadata": {},
   "outputs": [],
   "source": [
    "for num, item in enumerate(soup.find_all(lambda tag: tag.has_attr('class') and len(tag)==1 and tag['class'] == [\"item_time\"])):\n",
    "    result_menet[num]['date'] = item.text\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "e2db7256-18af-4160-ae6d-70863aa08427",
   "metadata": {},
   "outputs": [],
   "source": [
    "for _ in result_menet: _['date'] = datetime.strptime(_['date'], '%Y-%m-%d').date()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d5997d4d-72a5-40bc-86eb-f24718eb97a8",
   "metadata": {},
   "source": [
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3b065947-d0b6-4fa6-b94a-5237acc7bcbf",
   "metadata": {},
   "source": [
    "## 爬取pharnexcloud"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "a7daf37d-cce1-46fe-b162-5b9b937055e5",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://www.pharnexcloud.com/zixun')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "bfc4fc9b-7334-440e-b700-9897a5b3ecae",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "0e182927-4ba8-45e6-9c2b-b73d6b19aa1a",
   "metadata": {},
   "outputs": [],
   "source": [
    "dates = soup.find_all(lambda tag:tag.has_attr('class') and tag['class']==['date'])\n",
    "dates = [_.text for _ in dates]\n",
    "dates = [_ for _  in dates if _ != '']\n",
    "dates = [datetime.strptime(_.split(' ')[0], '%Y-%m-%d').date() for _ in dates]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "561a474c-6386-4861-86db-9afffe55a38f",
   "metadata": {},
   "outputs": [],
   "source": [
    "result = soup.find_all('a', class_ = 'img-content')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3bcaaf95-3889-4e51-abdc-262f2731ebf1",
   "metadata": {},
   "outputs": [],
   "source": [
    "def query_tilte_url(item):\n",
    "    title = item.find_next()['alt']\n",
    "    url = 'https://www.pharnexcloud.com' + item['href']\n",
    "    return {\n",
    "        'title': title,\n",
    "        'url': url\n",
    "    }\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "ff61ae62-435f-4343-b0ad-f851d5b309c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "result_pharnexcloud = list(map(query_tilte_url, result))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "f35002a9-9c79-49b3-8d3d-e2d998d17894",
   "metadata": {},
   "outputs": [],
   "source": [
    "for no, item in enumerate(result_pharnexcloud): item['date'] = dates[no]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dd24a11d-bfae-4006-b5fa-d4b2333f27c3",
   "metadata": {},
   "source": [
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "561321f3-7611-402b-9980-572b8790dd2a",
   "metadata": {},
   "source": [
    "## 爬取bydrug"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "2b1a0cb2-08ab-4a5a-81fe-215ac8370c4c",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://bydrug.pharmcube.com/')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "784c422e-7205-4ef2-a20f-a7ab2862d260",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "1692b564-5c86-49a3-83ba-0fdc55fbc355",
   "metadata": {},
   "outputs": [],
   "source": [
    "datas = soup.find_all('div', class_= 'mf-flex mf-items-center')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "09e4af5a-a295-4651-93be-da0a50eb1959",
   "metadata": {},
   "outputs": [],
   "source": [
    "datas = datas[1:]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "fed21537-3c8a-4c26-aa5a-499083e1ff38",
   "metadata": {},
   "outputs": [],
   "source": [
    "item = datas[0]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "55f8cd94-52a3-4657-a1c3-efd78b9bde15",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_info(item):\n",
    "    title = item.text.strip()\n",
    "    url = item.find('a')['href']\n",
    "    date = re.findall(r'\\d{4}-\\d{2}-\\d{2}', requests.get(url).text) [0]\n",
    "    date = datetime.strptime(date, '%Y-%m-%d').date()\n",
    "    return {\n",
    "        'title': title,\n",
    "        'url': url,\n",
    "        'date': date\n",
    "    }\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "0884d3a2-d23a-4406-a5fa-d6cdfcc7b454",
   "metadata": {},
   "outputs": [],
   "source": [
    "result_bydrug = [get_info(item) for _ in datas]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d83e75c-d3aa-4f25-a28b-648b6a0f4639",
   "metadata": {},
   "source": [
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9b42840a-d0e6-4d3a-8493-d330c6ddf9cd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "8e3e4a8f-a3a3-4629-9d84-70e910fdeec8",
   "metadata": {},
   "outputs": [],
   "source": [
    "## 爬取https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31250"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "7ea97866-9688-4312-8a33-adc4d47dede2",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get('https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31250')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5aa57827-08f6-4d59-8f04-78138461ba65",
   "metadata": {},
   "outputs": [],
   "source": [
    "soup = BeautifulSoup(r.text, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "f27d1312-89d4-4489-bd85-ee74bb266a20",
   "metadata": {},
   "outputs": [],
   "source": [
    "all = soup.find_all(class_='bwTitleLink')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "d4e8317d-be81-442f-a3f9-613f291031e9",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_info(item):\n",
    "    \n",
    "    title = item.parent.text\n",
    "    title = [_ for _ in all[7].parent.text.split('\\n') if _ !=''][0]\n",
    "    url = 'https://www.businesswire.com/' + item.parent.find_all('a')[0]['href']\n",
    "    date_str = item.parent.find('time').text.strip().split('-')[0].strip()\n",
    "    date = datetime.strptime(date_str, '%m/%d/%Y') \n",
    "    return {\n",
    "        'title': title,\n",
    "        'url': url,\n",
    "        'date': date\n",
    "    }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "d4a5c584-98da-401c-ad97-300749fb2140",
   "metadata": {},
   "outputs": [],
   "source": [
    "result_businesswire = [get_info(_) for _ in all]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4831a624-6bc7-446e-82b2-f6154e5c0800",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "18a976a5-d224-47e4-814b-345b2becd9ec",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "96fe984e-4e4f-4f0b-bbe5-8d1502fc2970",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = [*result_menet, *result_pharnexcloud, *result_bydrug, *result_businesswire]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "5bd2afbc-8b9a-4118-ba9c-a4dbf5c64bc4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918542283/fr',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918143666/en/InnoCare-Announces-Approval-of-Clinical-Trial-of-BCL2-Inhibitor-ICP-248-for-Acute-Myeloid-Leukemia-in-China',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918360574/en/Evecxia-Therapeutics-ACCESS-CHINA-Partnering-Forum',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918852695/en/Axonics-Prevails-in-Patent-Infringement-Lawsuit-with-Medtronic',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918762977/en/AHF-Misuse-of-Antibiotics-Endangers-Millions-Worldwide',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918570638/en/IDEX-Corporation-Declares-Regular-Quarterly-Cash-Dividend',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240917998093/en/CDC-Awards-Grant-to-NAFC-Phreesia-and-Health.Equity.Outcomes.-to-Tackle-Public-Health-Challenge-of-Urinary-Incontinence',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918481321/en/Wedgewood-Launches-Compounded-Molnupiravir-for-the-Treatment-of-Feline-Infectious-Peritonitis-FIP',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918451934/en/GE-HealthCare-announces-cash-dividend-for-third-quarter-of-2024',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918586347/en/Ardent-Health-Completes-Term-Loan-Repricing',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918495430/en/Rockwell-Medical-Named-a-Fortune-Best-Workplaces-in-Manufacturing-Production',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918066146/en/Exicure-Inc.-Receives-Extension-from-Nasdaq-Hearings-Panel',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240904051499/zh-CN',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918513887/en/New-Face-the-Fight%C2%AE-Support-for-Veterans-in-Advance-of-Veterans-Suicide-Awareness-and-Prevention-Day-Sept.-22',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918832722/en/August-Health-Launches-Billing-Payments-Platform',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918487263/en/SurGenTec-Wins-Two-Spine-Technology-Awards-for-2024',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918024917/nl',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918478357/it',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918358965/en/ustwo-Appoints-Nicki-Sprinz-as-CEO-as-Company-Continues-to-Grow-and-Build-Breakthrough-Digital-Experiences-as-a-Values-Driven-Agency',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240917000288/en/Leo-Loro-Senior-Director-U.S.-Healthcare-and-Lifesciences-at-Microsoft-Receives-Prestigious-HITEC-100-Recognition-for-2025',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918770745/en/Susan-G.-Komen%C2%AE-to-Host-MORE-THAN-PINK-Walk-in-the-Bay-Area-this-Fall',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918752552/en/CD137-Antibodies-Clinical-Trials-Market-Opportunity-Insight-2027---Over-80-Drugs-In-Clinical-Trials---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918250106/en/Wound-Management-Market-Strategies-and-Innovations-Report-2024-2029-Lucrative-Opportunities-in-Medical-Device-Outsourcing-Through-Partnerships-with-CMOs---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918514965/en/Human-Nutrition-Vitamin-and-Mineral-Ingredients-Global-Forecasts-2024-2030-Rising-Consumer-Awareness-and-Technological-Advances-Are-Driving-Transformational-Growth-Through-Personalized-Nutrition---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918190900/en/Healthcare-Building-Technologies-and-Services-Market-Research-2024-with-Case-Studies-from-Siemens-Artisight-and-ABB---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)}]"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_businesswire"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bb9631df-e9b0-4be8-b45b-1517b7cb4b9d",
   "metadata": {},
   "source": [
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "d4ccdbc6-3970-492b-9674-441efec06872",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': '新一代特异性溶栓药物重组人尿激酶原冠脉内应用新成果',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/20240918102202222_148102.shtml',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '18个独家中成药丸剂厉害了！31亿大品种领跑，天士力、达仁堂、雷允上上榜，12款新药发力',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409180941284128_148099.shtml',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '医药股“一哥”近50亿现金分红太惊人！东阿阿胶、华东……超5亿，10家中药企业亮眼',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409180938503850_148097.shtml',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '第十批集采58个超“卷”品种备战！550亿市场激战在即，扬子江、科伦、倍特蓄力',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409180936423642_148095.shtml',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '华海药业大丰收！16个新产品获批，5大畅销品种暴涨超100%，17款新药全力出击',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409180933473347_148093.shtml',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '华润双鹤发威了！拿下17个重磅品种，93个品种过评，6款新药、31个新品冲刺',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409131056175617_148090.shtml',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '$142亿“药王”登场！减肥“新宠”疯涨74%，“自免”赛道打得火热，三大中国药企成功突围',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409131054135413_148088.shtml',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '中成药贴膏剂龙头腾飞！奇正手握超20亿独家大品种，羚锐“14连涨”猛攻530亿市场',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409131051455145_148086.shtml',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '超200亿！海思科、人福、扬子江……33个1类新药热销，正大天晴4大爆款全力争先',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409131049324932_148084.shtml',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '“数智引领 价值重构”——2024全国慢病管理零售论坛顺利召开',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409091619471947_148075.shtml',\n",
       "  'date': datetime.date(2024, 9, 9)},\n",
       " {'title': '山东新时代爆发了！拿下9个重磅品种，猛攻1100亿市场，11款1类新药、44个新品蓄力',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/20240905102904294_148064.shtml',\n",
       "  'date': datetime.date(2024, 9, 5)},\n",
       " {'title': '492只医药股上半年成绩单！迈瑞净利润首破70亿，5家晋身10亿军团，甘李、海思科……翻倍',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409051027242724_148062.shtml',\n",
       "  'date': datetime.date(2024, 9, 5)},\n",
       " {'title': '63个中成药厉害了！独家品种大涨133%，3个超10亿品种亮眼，扬子江、济川、天士力霸屏',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409050941374137_148059.shtml',\n",
       "  'date': datetime.date(2024, 9, 5)},\n",
       " {'title': '信立泰厉害了！12款1类新药曝光，猛攻1300亿市场，5款新药上市可期',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/20240903141804184_148053.shtml',\n",
       "  'date': datetime.date(2024, 9, 3)},\n",
       " {'title': '“中药股王”发威！肝病用药狂卖26亿，14个独家中成药热销，8款重磅新药出击',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/202409031416261626_148051.shtml',\n",
       "  'date': datetime.date(2024, 9, 3)},\n",
       " {'title': '第十批集采24个品种备战！千亿市场齐鲁亮了，2大注射剂疯狂连涨，倍特、华海蓄力',\n",
       "  'url': 'https://www.menet.com.cn/info/202409/20240903141404144_148049.shtml',\n",
       "  'date': datetime.date(2024, 9, 3)},\n",
       " {'title': '2024年8月：183个品种过评，8款首仿药获批！石家庄四药领跑',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8503',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '2024年8月共17款创新药进入III期，6款来自国内药企，正大天晴、恒瑞医药……',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8502',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '阿斯利康PD-L1抗体Imfinzi引领膀胱癌治疗新突破：III期试验获积极结果',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8501',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '恒瑞医药瑞康曲妥珠单抗：非小细胞肺癌治疗新突破，CDE优先审评加速上市',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8500',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '强生首款双机制IL-23抑制剂Tremfya获批UC治疗，三适应症在手展现强大潜力',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8499',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '华海药业白消安注射液获FDA批准及孤儿药认定，市场竞争力再升级！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8498',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '中药市场稳健增长，OTC集采加剧药企洗牌：华润三九等巨头面临价格大考',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8497',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '国内4家细胞疗法上市公司市值/管线：科济药业、传奇生物、药明巨诺…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8496',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '国产降脂药新突破：齐鲁制药ω-3脂肪酸乙酯90软胶囊获批，市场销售额飙升5倍',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8495',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '诺和诺德口服GLP-1新疗法Amycretin减肥I期数据惊艳：12周减重13%！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8494',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '从合作到独立研发：信达生物ADC战略升级，赛诺菲3亿欧元投资助力',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8493',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '中秋佳节拒绝“甜蜜陷阱”，全球三款创新药物带来糖尿病治疗新希望',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8492',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '成都苑东生物制药实现原料制剂一体化，盐酸尼卡地平注射液ANDA获FDA认可',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8491',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '阿斯利康小分子PCSK9抑制剂在中国获批临床！血脂管理迎新突破',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8490',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '全球首款JAK抑制剂：德戈替尼乳膏获EMA积极意见，专注中重度CHE治疗',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8489',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '康诺亚创新突破：康悦达®成为国内首个获批IL-4Rα抗体，特应性皮炎治疗新选择',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8488',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '山东新华制药8700万技改项目公示，高端原料药年产能达701吨！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8487',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '集采规则再升级：同通用名品种价差缩小，创新+精细化设计是关键',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8486',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '当项目申报阶段遇上“B证的尽头是A证”：江苏联盟引领企业报价策略面临新挑战',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8485',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '福元医药再添重磅品种！琥珀酸亚铁片获批上市，抗贫血市场竞争加剧',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8484',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '安帝康生物获超2亿元A轮融资，加速抗流感新药玛氘诺沙韦的研发与商业化',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_8029',\n",
       "  'date': datetime.date(2024, 6, 26)},\n",
       " {'title': '国内核药再现大笔融资，是值得押注的赛道吗？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7794',\n",
       "  'date': datetime.date(2024, 4, 28)},\n",
       " {'title': '日本大财团三井物产和乐敦制药，47亿收购百年中医药品牌余仁生',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7795',\n",
       "  'date': datetime.date(2024, 4, 28)},\n",
       " {'title': '2024Q1季度：6家CGT公司上市',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7762',\n",
       "  'date': datetime.date(2024, 4, 23)},\n",
       " {'title': '2024年4月国内CGT投融资盘点',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7747',\n",
       "  'date': datetime.date(2024, 4, 18)},\n",
       " {'title': '英伟达投资5000万美金，“押注”AI制药：Recursion！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7716',\n",
       "  'date': datetime.date(2024, 4, 11)},\n",
       " {'title': 'TORL BioTherapeutics完成1.58亿美元融资，用于推进其ADC药物研发',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7720',\n",
       "  'date': datetime.date(2024, 4, 11)},\n",
       " {'title': 'Avenzo完成1.5亿美元A轮融资！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7707',\n",
       "  'date': datetime.date(2024, 4, 9)},\n",
       " {'title': 'Obsidian 完成C轮融资1.6亿美元！以推进TIL疗法OBX-115开发',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7703',\n",
       "  'date': datetime.date(2024, 4, 7)},\n",
       " {'title': '科研新突破！DNA纳米实现精准血栓治疗，药物递送技术新型解码…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7668',\n",
       "  'date': datetime.date(2024, 3, 27)},\n",
       " {'title': '基金取代创始人，成为这家国内biotech大股东',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7638',\n",
       "  'date': datetime.date(2024, 3, 19)},\n",
       " {'title': '伯瑞替尼肠溶胶囊定价出炉；完成巨额融资，这家小分子企业有何特色？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7453',\n",
       "  'date': datetime.date(2024, 1, 15)},\n",
       " {'title': '融资2.5亿美元！蓝鸟生物“找钱”新模式',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7382',\n",
       "  'date': datetime.date(2023, 12, 21)},\n",
       " {'title': '融资3700万美元！免疫新锐开发癌症新靶点T细胞接合器',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7364',\n",
       "  'date': datetime.date(2023, 12, 15)},\n",
       " {'title': '融资3.7亿元！推进CAR iPS-T细胞疗法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7356',\n",
       "  'date': datetime.date(2023, 12, 14)},\n",
       " {'title': '1600万美元！CGT CDMO领域又一起并购',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7318',\n",
       "  'date': datetime.date(2023, 12, 5)},\n",
       " {'title': '冬天不冷，20家CXO获超1亿元融资',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7319',\n",
       "  'date': datetime.date(2023, 12, 5)},\n",
       " {'title': '肿瘤疫苗biotech获得C轮融资，5.3亿元！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7253',\n",
       "  'date': datetime.date(2023, 11, 15)},\n",
       " {'title': 'CAR-T细胞疗法本年度最大规模IPO之一！融资20亿元',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7245',\n",
       "  'date': datetime.date(2023, 11, 14)},\n",
       " {'title': '抗肿瘤药物热度不减！今年最大一笔创新药融资，江苏药企拿下！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/trz_7217',\n",
       "  'date': datetime.date(2023, 11, 7)},\n",
       " {'title': '国内4家细胞疗法上市公司市值/管线：科济药业、传奇生物、药明巨诺…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8496',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '从合作到独立研发：信达生物ADC战略升级，赛诺菲3亿欧元投资助力',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8493',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '中秋佳节拒绝“甜蜜陷阱”，全球三款创新药物带来糖尿病治疗新希望',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8492',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '集采规则再升级：同通用名品种价差缩小，创新+精细化设计是关键',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8486',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '当项目申报阶段遇上“B证的尽头是A证”：江苏联盟引领企业报价策略面临新挑战',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8485',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '中药销售TOP10大洗牌：华润医药称霸，连花清瘟跌出前十',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8479',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '立项必看：立项为什么越来越难?',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8468',\n",
       "  'date': datetime.date(2024, 9, 11)},\n",
       " {'title': '中国药品市场三大终端销售全景：医院、基层与药店的变局与机遇',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8467',\n",
       "  'date': datetime.date(2024, 9, 10)},\n",
       " {'title': 'FDA观点：利多卡因/丙胺卡因外用制剂的物理和结构特性（Q3）与产品体内外性质的相关性',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8435',\n",
       "  'date': datetime.date(2024, 9, 5)},\n",
       " {'title': '2024年中药上市公司中报，六巨头净利超10亿，云南白药领跑！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8434',\n",
       "  'date': datetime.date(2024, 9, 4)},\n",
       " {'title': '集采预测：多治疗领域药品或将被列入名单',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8427',\n",
       "  'date': datetime.date(2024, 9, 4)},\n",
       " {'title': '既是API也是辅料！详解这款可能是处方组成最简单的外用制剂',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8426',\n",
       "  'date': datetime.date(2024, 9, 4)},\n",
       " {'title': '2024盘点丨银屑病治疗新突破！生物制剂与小分子靶向药最新梳理',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8424',\n",
       "  'date': datetime.date(2024, 9, 3)},\n",
       " {'title': '全球畅销孤儿药TOP10预测，两款国产药在榜！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8423',\n",
       "  'date': datetime.date(2024, 9, 3)},\n",
       " {'title': '从复星凯特到传奇生物：中国CAR-T细胞治疗市场六强争霸，商业化前景展望',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8397',\n",
       "  'date': datetime.date(2024, 8, 29)},\n",
       " {'title': '一文了解德曲妥珠单抗（DS-8201）：上市进展、适应症、价格、市场表现...',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8392',\n",
       "  'date': datetime.date(2024, 8, 28)},\n",
       " {'title': '从2000到2024：FDA批准局部皮肤用凝胶剂25年大盘点',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8376',\n",
       "  'date': datetime.date(2024, 8, 27)},\n",
       " {'title': '潜力黑马IDEAYA：TOP药企争相携手，独家获百奥赛图首创ADC项目全球许可权',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8360',\n",
       "  'date': datetime.date(2024, 8, 23)},\n",
       " {'title': '中药创新热潮：政策与市场双轮驱动，经典名方制剂注册申请激增',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8354',\n",
       "  'date': datetime.date(2024, 8, 22)},\n",
       " {'title': '浅析不同定量方法中积分方法的玄机妙设',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sd_8347',\n",
       "  'date': datetime.date(2024, 8, 22)},\n",
       " {'title': '药品反垄断指南出炉：全领域覆盖，力促公平竞争新生态',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_8341',\n",
       "  'date': datetime.date(2024, 8, 21)},\n",
       " {'title': '下月起执行！九大类耗材品种开始降价，平均降价83.46%……',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_8020',\n",
       "  'date': datetime.date(2024, 6, 24)},\n",
       " {'title': '国家新规出台，全面彻查公立医院欠款问题！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7970',\n",
       "  'date': datetime.date(2024, 6, 13)},\n",
       " {'title': '国家医保局最新指令，全国严查大型医疗设备！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7904',\n",
       "  'date': datetime.date(2024, 5, 30)},\n",
       " {'title': '新政策！北京发文支持CGT药物等快速形成产业增量',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7885',\n",
       "  'date': datetime.date(2024, 5, 27)},\n",
       " {'title': '注射剂用覆膜胶塞的缺陷与对策',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7567',\n",
       "  'date': datetime.date(2024, 2, 28)},\n",
       " {'title': '重磅！第三批鼓励仿制药品目录出炉！39品种纳入，帕替司兰、伏环孢素等',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7395',\n",
       "  'date': datetime.date(2023, 12, 26)},\n",
       " {'title': '福建第四批化药集采拟中选结果，间苯三酚降价92%！30+药企扎堆申报',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_7345',\n",
       "  'date': datetime.date(2023, 12, 13)},\n",
       " {'title': '国家药监局发文，GLP认证新《办法》7月1日执行！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6660',\n",
       "  'date': datetime.date(2023, 6, 25)},\n",
       " {'title': '注射剂注意！《中国药典》通则（0102）注射剂修订！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6640',\n",
       "  'date': datetime.date(2023, 6, 20)},\n",
       " {'title': '最新！CDE更新11条一般技术性问题！涉及审评审批、MAH变更等',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6618',\n",
       "  'date': datetime.date(2023, 6, 15)},\n",
       " {'title': 'GLP-1必备SNAC！原辅料全产业链平台完整打造，天吉生物未来可期！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6612',\n",
       "  'date': datetime.date(2023, 6, 14)},\n",
       " {'title': '重磅！医保目录调整方案公开征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6597',\n",
       "  'date': datetime.date(2023, 6, 13)},\n",
       " {'title': '2023年中国科学院院士增选79名，药剂学方向优先！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6590',\n",
       "  'date': datetime.date(2023, 6, 12)},\n",
       " {'title': 'CDE最新发布通知，公开征求GCP指导原则！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6506',\n",
       "  'date': datetime.date(2023, 5, 30)},\n",
       " {'title': '鼓励研发！卫健委开出29个临床急需儿童用药，均未在国内上市！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6498',\n",
       "  'date': datetime.date(2023, 5, 29)},\n",
       " {'title': '医美新势力！CMDE发布2项重磅指导原则，涉及重组胶原蛋白！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6497',\n",
       "  'date': datetime.date(2023, 5, 29)},\n",
       " {'title': '重磅！《关于加强委托生产药品上市许可持有人监管工作的通知》公开征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6477',\n",
       "  'date': datetime.date(2023, 5, 25)},\n",
       " {'title': 'CDE重磅！《关于无参比制剂品种仿制研究的公告（征求意见稿）》征求意见！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6476',\n",
       "  'date': datetime.date(2023, 5, 25)},\n",
       " {'title': '重磅！全国中成药集采正式文件公布！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/zc_6453',\n",
       "  'date': datetime.date(2023, 5, 22)},\n",
       " {'title': '2024年第35周09.02-09.08全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8478',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '2024年第35周09.02-09.08全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8477',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '2024年第35周09.02-09.08国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8476',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '2024年第35周09.02-09.08国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8475',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '2024年第35周09.02-09.08国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8474',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '2024年8月：143款新药获批临床！9款创新药获批上市，涉及信达生物…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8473',\n",
       "  'date': datetime.date(2024, 9, 11)},\n",
       " {'title': '2024年第34周08.26-09.01全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8447',\n",
       "  'date': datetime.date(2024, 9, 6)},\n",
       " {'title': '2024年第34周08.26-09.01全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8446',\n",
       "  'date': datetime.date(2024, 9, 6)},\n",
       " {'title': '2024年第34周08.26-09.01国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8445',\n",
       "  'date': datetime.date(2024, 9, 6)},\n",
       " {'title': '2024年第34周08.26-09.01国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8444',\n",
       "  'date': datetime.date(2024, 9, 6)},\n",
       " {'title': '2024年第34周08.26-09.01国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8443',\n",
       "  'date': datetime.date(2024, 9, 6)},\n",
       " {'title': '2024年8月共有183个品种过评！齐鲁制药、汇宇制药、恒瑞医药三足鼎立…',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8433',\n",
       "  'date': datetime.date(2024, 9, 4)},\n",
       " {'title': '2024年第33周08.19-08.25全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8406',\n",
       "  'date': datetime.date(2024, 8, 30)},\n",
       " {'title': '2024年第33周08.19-08.25全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8405',\n",
       "  'date': datetime.date(2024, 8, 30)},\n",
       " {'title': '2024年第33周08.19-08.25国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8404',\n",
       "  'date': datetime.date(2024, 8, 30)},\n",
       " {'title': '2024年第33周08.19-08.25国内仿制药/生物类似物申报/审批数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8403',\n",
       "  'date': datetime.date(2024, 8, 30)},\n",
       " {'title': '2024年第33周08.19-08.25国内创新药/改良型新药申请临床/获批临床/申请上市/获批上市数据分析',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8402',\n",
       "  'date': datetime.date(2024, 8, 30)},\n",
       " {'title': '2024年第32周08.12-08.18全球创新药研发概览',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8359',\n",
       "  'date': datetime.date(2024, 8, 23)},\n",
       " {'title': '2024年第32周08.12-08.18全球医药大健康行业投融资数据',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8358',\n",
       "  'date': datetime.date(2024, 8, 23)},\n",
       " {'title': '2024年第32周08.12-08.18国内医药大健康行业政策法规汇总',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/bg_8357',\n",
       "  'date': datetime.date(2024, 8, 23)},\n",
       " {'title': '群贤共聚，论道医药！第五届CMC-China中国国际生物&化学制药博览会圆满结束！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6793',\n",
       "  'date': datetime.date(2023, 8, 10)},\n",
       " {'title': '深耕代谢疾病：君圣泰递交IPO申请，海普瑞为大股东之一（附招股书）',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6611',\n",
       "  'date': datetime.date(2023, 6, 14)},\n",
       " {'title': '千位药企掌门聚苏州！第四届中国API Summit开始报名！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6553',\n",
       "  'date': datetime.date(2023, 6, 12)},\n",
       " {'title': '新环境下企业拓展OTC赛道新思路！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6568',\n",
       "  'date': datetime.date(2023, 6, 8)},\n",
       " {'title': '10个一致性评价受理号获批！一品种集齐36家过评！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6559',\n",
       "  'date': datetime.date(2023, 6, 7)},\n",
       " {'title': '制药人，不懂点合成生物学，就有点落后了！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6558',\n",
       "  'date': datetime.date(2023, 6, 7)},\n",
       " {'title': '就在成都！沉浸式交流：小分子工艺开发和质量分析科学，一文速览议程！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6554',\n",
       "  'date': datetime.date(2023, 6, 6)},\n",
       " {'title': '266亿！浅析黏膜给药制剂销售趋势及市场格局',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6544',\n",
       "  'date': datetime.date(2023, 6, 5)},\n",
       " {'title': '报名开始！8月苏州，中国绿色制药技术大会',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6534',\n",
       "  'date': datetime.date(2023, 6, 2)},\n",
       " {'title': '基因治疗，国内药企该如何布局并弯道超车？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6524',\n",
       "  'date': datetime.date(2023, 6, 1)},\n",
       " {'title': '改良新药已开卷，企业的求生法则',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6502',\n",
       "  'date': datetime.date(2023, 5, 29)},\n",
       " {'title': '溯源而上！这场大会，体现抗体、小分子、细胞基因疗法、核酸等差异化竞争与合作',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6461',\n",
       "  'date': datetime.date(2023, 5, 23)},\n",
       " {'title': '就在这周五：相约泰州，纳米抗体新药论坛！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6441',\n",
       "  'date': datetime.date(2023, 5, 19)},\n",
       " {'title': '倒计时3天！免报名费！来石家庄，听外用制剂、高端注射剂、改良新药与复杂制剂内容！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6369',\n",
       "  'date': datetime.date(2023, 5, 9)},\n",
       " {'title': '药物工艺开发及质量控制要点峰会，6月14-15日，成都开幕！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6362',\n",
       "  'date': datetime.date(2023, 5, 8)},\n",
       " {'title': '以药为融 | 万人圈友大聚会@第五届CMC-China制药博览会',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6351',\n",
       "  'date': datetime.date(2023, 5, 6)},\n",
       " {'title': '院士领衔，专家齐聚，群贤毕至，待您加入！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6341',\n",
       "  'date': datetime.date(2023, 5, 5)},\n",
       " {'title': '纳米抗体30周年：行业新生赛道的机遇与挑战',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6305',\n",
       "  'date': datetime.date(2023, 4, 26)},\n",
       " {'title': '限时免费报名！石家庄MAH&DDS制剂合作大会，各路专家带你飞！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6242',\n",
       "  'date': datetime.date(2023, 4, 18)},\n",
       " {'title': '下一站再聚 | 改良型新药趋势与合作交流大会圆满落幕',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/hy_6213',\n",
       "  'date': datetime.date(2023, 4, 13)},\n",
       " {'title': '2024年8月：183个品种过评，8款首仿药获批！石家庄四药领跑',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8503',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '2024年8月共17款创新药进入III期，6款来自国内药企，正大天晴、恒瑞医药……',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8502',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '阿斯利康PD-L1抗体Imfinzi引领膀胱癌治疗新突破：III期试验获积极结果',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8501',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '恒瑞医药瑞康曲妥珠单抗：非小细胞肺癌治疗新突破，CDE优先审评加速上市',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8500',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '强生首款双机制IL-23抑制剂Tremfya获批UC治疗，三适应症在手展现强大潜力',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8499',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '华海药业白消安注射液获FDA批准及孤儿药认定，市场竞争力再升级！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8498',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '中药市场稳健增长，OTC集采加剧药企洗牌：华润三九等巨头面临价格大考',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8497',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': '国产降脂药新突破：齐鲁制药ω-3脂肪酸乙酯90软胶囊获批，市场销售额飙升5倍',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8495',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '诺和诺德口服GLP-1新疗法Amycretin减肥I期数据惊艳：12周减重13%！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8494',\n",
       "  'date': datetime.date(2024, 9, 14)},\n",
       " {'title': '成都苑东生物制药实现原料制剂一体化，盐酸尼卡地平注射液ANDA获FDA认可',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8491',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '阿斯利康小分子PCSK9抑制剂在中国获批临床！血脂管理迎新突破',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8490',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '全球首款JAK抑制剂：德戈替尼乳膏获EMA积极意见，专注中重度CHE治疗',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8489',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '康诺亚创新突破：康悦达®成为国内首个获批IL-4Rα抗体，特应性皮炎治疗新选择',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8488',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '山东新华制药8700万技改项目公示，高端原料药年产能达701吨！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8487',\n",
       "  'date': datetime.date(2024, 9, 13)},\n",
       " {'title': '福元医药再添重磅品种！琥珀酸亚铁片获批上市，抗贫血市场竞争加剧',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8484',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '君实生物特瑞普利单抗再迎新突破：联合西妥昔单抗治疗头颈部癌获批临床',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8483',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': 'BridgeBio放弃AAV5基因疗法BBP-631，聚焦ATTR-CM新药Acoramidis冲刺FDA',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8482',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '信达生物IBI363：PD-1/IL-2α双特异性抗体临床数据抢眼，DCR超70%！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8481',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '恒瑞医药阿帕替尼用量优化获批，剂量减半疗效不减，惠及晚期胃癌患者',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8480',\n",
       "  'date': datetime.date(2024, 9, 12)},\n",
       " {'title': '百济神州PRMT5抑制剂BGB-58067临床试验申请获受理，引领抗癌前沿',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/sx_8472',\n",
       "  'date': datetime.date(2024, 9, 11)},\n",
       " {'title': '国际疾病分类编码在线查询（ICD-10&ICD-11）',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8168',\n",
       "  'date': datetime.date(2024, 7, 22)},\n",
       " {'title': '5万+全国各省市中药饮片炮制规范-在线免费查询啦！',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8142',\n",
       "  'date': datetime.date(2024, 7, 15)},\n",
       " {'title': '2020《中国药典》电子版官网在线查询入口|中国药典检索🔍',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8097',\n",
       "  'date': datetime.date(2024, 7, 10)},\n",
       " {'title': '【调研必看】中国慢性疾病统计数据查询方法-28个权威网站',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8081',\n",
       "  'date': datetime.date(2024, 7, 4)},\n",
       " {'title': '分享两种印度仿制药品信息查询方法',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8063',\n",
       "  'date': datetime.date(2024, 7, 1)},\n",
       " {'title': '国谈药品是什么意思？与集采药品有什么区别？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_8053',\n",
       "  'date': datetime.date(2024, 6, 26)},\n",
       " {'title': '<一文看懂>保健食品备案和注册的区别',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7981',\n",
       "  'date': datetime.date(2024, 6, 13)},\n",
       " {'title': '特殊医学用途配方食品有哪些?如何查询？',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7982',\n",
       "  'date': datetime.date(2024, 6, 12)},\n",
       " {'title': '保健食品注册信息在线查询平台',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7946',\n",
       "  'date': datetime.date(2024, 6, 3)},\n",
       " {'title': '原研药-创新药-全球药品研发进度在线查询平台',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7930',\n",
       "  'date': datetime.date(2024, 6, 1)},\n",
       " {'title': 'ICH指导原则中英文版下载',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7912',\n",
       "  'date': datetime.date(2024, 5, 30)},\n",
       " {'title': '全国快速预审通道发明专利1-6个月授权',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7840',\n",
       "  'date': datetime.date(2024, 5, 14)},\n",
       " {'title': '我国药品定价政策及所需考虑的市场因素',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7831',\n",
       "  'date': datetime.date(2024, 5, 10)},\n",
       " {'title': '中药保护品种：官网目录信息收载数据4000+',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7838',\n",
       "  'date': datetime.date(2024, 5, 10)},\n",
       " {'title': '化学药品注册分类标准及申报资料要求(新版原文)',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7784',\n",
       "  'date': datetime.date(2024, 4, 26)},\n",
       " {'title': '请查收！《中药注册分类及申报材料要求》',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7791',\n",
       "  'date': datetime.date(2024, 4, 25)},\n",
       " {'title': '中医诊疗方案数据库:收载历史多版本400多个治疗方案',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7741',\n",
       "  'date': datetime.date(2024, 4, 17)},\n",
       " {'title': '中医临床诊疗术语一览表(收载官网全部术语4705个)',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7735',\n",
       "  'date': datetime.date(2024, 4, 16)},\n",
       " {'title': '法国药品数据库-药品查询方法详细讲解<实操案列>',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7628',\n",
       "  'date': datetime.date(2024, 3, 14)},\n",
       " {'title': 'Sumitomo Pharma日本百年Top10药企简史——住友制药',\n",
       "  'url': 'https://www.pharnexcloud.com/zixun/kp_7606',\n",
       "  'date': datetime.date(2024, 3, 7)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'CXO&科研试剂中报总结：环比改善，从分化中寻找确定性增长',\n",
       "  'url': 'https://bydrug.pharmcube.com/report/detail/f7d3935d95d94adea830b346341ff226',\n",
       "  'date': datetime.date(2024, 9, 18)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918542283/fr',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918143666/en/InnoCare-Announces-Approval-of-Clinical-Trial-of-BCL2-Inhibitor-ICP-248-for-Acute-Myeloid-Leukemia-in-China',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918360574/en/Evecxia-Therapeutics-ACCESS-CHINA-Partnering-Forum',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918852695/en/Axonics-Prevails-in-Patent-Infringement-Lawsuit-with-Medtronic',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918762977/en/AHF-Misuse-of-Antibiotics-Endangers-Millions-Worldwide',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918570638/en/IDEX-Corporation-Declares-Regular-Quarterly-Cash-Dividend',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240917998093/en/CDC-Awards-Grant-to-NAFC-Phreesia-and-Health.Equity.Outcomes.-to-Tackle-Public-Health-Challenge-of-Urinary-Incontinence',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918481321/en/Wedgewood-Launches-Compounded-Molnupiravir-for-the-Treatment-of-Feline-Infectious-Peritonitis-FIP',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918451934/en/GE-HealthCare-announces-cash-dividend-for-third-quarter-of-2024',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918586347/en/Ardent-Health-Completes-Term-Loan-Repricing',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918495430/en/Rockwell-Medical-Named-a-Fortune-Best-Workplaces-in-Manufacturing-Production',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918066146/en/Exicure-Inc.-Receives-Extension-from-Nasdaq-Hearings-Panel',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240904051499/zh-CN',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918513887/en/New-Face-the-Fight%C2%AE-Support-for-Veterans-in-Advance-of-Veterans-Suicide-Awareness-and-Prevention-Day-Sept.-22',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918832722/en/August-Health-Launches-Billing-Payments-Platform',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918487263/en/SurGenTec-Wins-Two-Spine-Technology-Awards-for-2024',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918024917/nl',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918478357/it',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918358965/en/ustwo-Appoints-Nicki-Sprinz-as-CEO-as-Company-Continues-to-Grow-and-Build-Breakthrough-Digital-Experiences-as-a-Values-Driven-Agency',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240917000288/en/Leo-Loro-Senior-Director-U.S.-Healthcare-and-Lifesciences-at-Microsoft-Receives-Prestigious-HITEC-100-Recognition-for-2025',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918770745/en/Susan-G.-Komen%C2%AE-to-Host-MORE-THAN-PINK-Walk-in-the-Bay-Area-this-Fall',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918752552/en/CD137-Antibodies-Clinical-Trials-Market-Opportunity-Insight-2027---Over-80-Drugs-In-Clinical-Trials---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918250106/en/Wound-Management-Market-Strategies-and-Innovations-Report-2024-2029-Lucrative-Opportunities-in-Medical-Device-Outsourcing-Through-Partnerships-with-CMOs---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918514965/en/Human-Nutrition-Vitamin-and-Mineral-Ingredients-Global-Forecasts-2024-2030-Rising-Consumer-Awareness-and-Technological-Advances-Are-Driving-Transformational-Growth-Through-Personalized-Nutrition---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)},\n",
       " {'title': 'Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)',\n",
       "  'url': 'https://www.businesswire.com//news/home/20240918190900/en/Healthcare-Building-Technologies-and-Services-Market-Research-2024-with-Case-Studies-from-Siemens-Artisight-and-ABB---ResearchAndMarkets.com',\n",
       "  'date': datetime.datetime(2024, 9, 18, 0, 0)}]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "74422c70-a6dd-4cf4-a371-d4d501a91fcd",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_yesterday():\n",
    "    import datetime  \n",
    "  \n",
    "    # 获取当前日期  \n",
    "    today = datetime.date.today()  \n",
    "      \n",
    "    # 获取昨天的日期  \n",
    "    yesterday = today - datetime.timedelta(days=1)  \n",
    "      \n",
    "    # 将昨天的日期格式化为“年-月-日”  \n",
    "    return yesterday\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "6f0e4844-d558-43f1-96fe-564b0411ed2c",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = [_ for _ in results if _['date'] == get_yesterday()]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "ab40c614-e850-4114-b2dd-e64a733fb6aa",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = [_[-1] for _ in {_['title']: _ for _ in results}.items()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ec14a08b-9499-4992-89b2-e320629fbb56",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "6e112121-b886-447e-9ce7-886ca7154b26",
   "metadata": {},
   "outputs": [],
   "source": [
    "def summarize(url):\n",
    "    context = requests.get('https://r.jina.ai/'+url).text\n",
    "    url_pattern = re.compile(r'\\bhttps?:\\/\\/[^\\s/$.?#].[^\\s]*\\b')  \n",
    "    cleaned_text = url_pattern.sub('', context)\n",
    "    context = cleaned_text[:6000] if len(cleaned_text)>6000  else cleaned_text\n",
    "    context = \"请尽量简洁总结以下内容，并发表你的观点,文字不得超过150字\\n\"+context.replace(\"\\n\",\"\")[:6000]\n",
    "    client = OpenAI(\n",
    "    api_key='sk-69c9bf69fa2b4d2985834d6dc17c0790', # 如何获取API Key：https://help.aliyun.com/zh/model-studio/developer-reference/get-api-key\n",
    "    base_url=\"https://dashscope.aliyuncs.com/compatible-mode/v1\"\n",
    "    )\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"qwen-max\", # 更多模型请参见模型列表文档。\n",
    "        messages=[{\"role\": \"user\", \"content\": context}]\n",
    "    )\n",
    "    print(completion.choices[0].message.content)\n",
    "    \n",
    "    return completion.choices[0].message.content\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c875a1b4-6ce9-4b2d-a5f4-d7c27e53ecfd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "新一代特异性溶栓药物重组人尿激酶原在冠脉内应用展现新成果，尤其针对急性ST段抬高型心肌梗死(STEMI)患者。该疗法通过冠脉内直接注入，能有效降低术后“无复流”现象，提升血流恢复，且出血风险低。ERUPTION研究证实其能显著改善PCI术后患者微循环灌注。这标志着在STEMI治疗上的一大进步，强调了针对高血栓负荷患者的个性化治疗策略重要性。\n",
      "------------------------------------------------------------------------------------------------------------------------\n",
      "18种独家中成药丸剂表现突出，市场规模达31亿，主要应用于心脑血管疾病治疗，天士力、达仁堂、雷允上等企业名列前茅。市场中，12款新药正在推进，反映出中成药丸剂领域的活跃研发趋势和市场潜力。这不仅展示了传统中医药的现代发展，也体现了行业对慢性疾病治疗需求的持续关注。\n",
      "------------------------------------------------------------------------------------------------------------------------\n",
      "医药股领域迎来分红盛宴，2024年中期超过70家企业披露分红方案，其中6成系首次。亮点包括14家企业提出10派5元以上现金分红，尤其是中药企业表现突出，10家中药企业分红亮眼，显示出强劲盈利与回馈投资者的决心。医药股“一哥”更是以接近50亿的巨额现金分红引领风骚，东阿阿胶、华东医药等紧随其后，分红金额超过5亿。高分红比例彰显企业财务健康与对投资者的重视，体现了资本市场分红常态化的积极趋势。这不仅增强了投资者信心，也反映了医药行业整体向好的经营态势。\n",
      "------------------------------------------------------------------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "for _ in results:\n",
    "   try:\n",
    "        _['context'] = summarize(_['url'])\n",
    "      \n",
    "   except Exception as e:\n",
    "       print(e)\n",
    "   print('------'*20)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1b1e4716-0616-4a67-8257-b92be818aabf",
   "metadata": {},
   "outputs": [],
   "source": [
    "results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "87611f74-37de-407e-9c2d-080854b387bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_flag(item):\n",
    "    \n",
    "    title = item['title']\n",
    "    url = item['url']\n",
    "    date = item['date'].strftime('%Y-%m-%d')\n",
    "    context = item['context']\n",
    "    return f\"\"\"\n",
    "  <h4 style=\"color:black; margin-top:10px\">  \n",
    "    {title}  \n",
    "  </h4>  \n",
    "  \n",
    "  <span> {date}</span>  \n",
    "  <div  style=\"margin-bottom: 20px;\">  \n",
    "    <p>  \n",
    "      {context}  \n",
    "    </p>  \n",
    "    <span><a href={url}>👉查看更多内容</a></span>  \n",
    "  </div>  \n",
    "  <hr />  \n",
    "  \n",
    "  \n",
    "\"\"\".strip()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "73299fd6-fc34-4021-b080-7b371d6bbdaf",
   "metadata": {},
   "outputs": [],
   "source": [
    "htmls = [get_flag(item) for item in results]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ccc11a3e-c509-469a-b482-4638938c2070",
   "metadata": {},
   "outputs": [],
   "source": [
    "htmls = \"\".join(htmls)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ba7c62ff-b1a6-4fda-a184-6a6f654f1733",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "104b1176-d573-48df-a3b1-210f84bb921e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "302ce6ca-77be-4f47-9f9a-29630cedb4fd",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_token():\n",
    "    corp_id = 'ww9bffa3285527b3c8'\n",
    "    secret = '_uOqAIKUWnRgFIY23gItQ5fX4OeWRpYu1G86Gvk7EUw'\n",
    "    url = f'https://qyapi.weixin.qq.com/cgi-bin/gettoken?corpid={corp_id}&corpsecret={secret}'\n",
    "    return requests.get(url).json()['access_token']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "624bafc4-b425-4008-9bbf-b93b694d8027",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7aee5511-b83f-4bc6-b565-9d30cc802e0d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "479b379b-6254-4732-93f9-f6b7e023b76f",
   "metadata": {},
   "outputs": [],
   "source": [
    "try:\n",
    "    html_text = f\"\"\"  \n",
    "<!DOCTYPE html>  \n",
    "<html lang=\"en\">  \n",
    "  \n",
    "<head>  \n",
    "  <meta charset=\"UTF-8\">  \n",
    "  <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no\">  \n",
    "  <title>Document</title>  \n",
    "</head>  \n",
    "<style>  \n",
    "  /* 全局样式 */  \n",
    "  * {{  \n",
    "    margin: 0;  \n",
    "    padding: 0;  \n",
    "  }}  \n",
    "  \n",
    "  h4 {{  \n",
    "    text-align: center;  \n",
    "     text-shadow: 2px 2px 4px rgba(15, 47, 206, 0.5);\n",
    "  }}  \n",
    "  \n",
    "  em {{  \n",
    "    font-family: 'Franklin Gothic Medium', 'Arial Narrow', Arial, sans-serif;  \n",
    "    color: silver;  \n",
    "  }}  \n",
    "  \n",
    "  div > p {{  \n",
    "    width: 96%;  \n",
    "    padding: 2%;  \n",
    "  }}  \n",
    "  \n",
    "  a {{  \n",
    "    color: #1e90ff;  \n",
    "    text-decoration: none;  \n",
    "    transition: color 0.3s;  \n",
    "  }}  \n",
    "  \n",
    "  a:hover {{  \n",
    "    color: #ff6347;  \n",
    "  }}  \n",
    "  \n",
    "  p {{  \n",
    "    text-indent: 2em;  \n",
    "    text-align: justify;  \n",
    "  }}  \n",
    "\n",
    "  div {{\n",
    "      margin-bottom: 10px;\n",
    "  }}\n",
    "</style>  \n",
    "  \n",
    "<body>  \n",
    "  <h4 style=\"color:pink;\">  \n",
    "    {title}  \n",
    "  </h4>  \n",
    "  \n",
    "  <span> 🗓️ {date}</span>  \n",
    "  <div>  \n",
    "    <p>  \n",
    "      {context}  \n",
    "    </p>  \n",
    "    <span><a href={url}>👉查看更多内容</a></span>  \n",
    "  </div>  \n",
    "  <hr />  \n",
    "  \n",
    "</body>  \n",
    "  \n",
    "</html>  \n",
    "\"\"\"\n",
    "except:\n",
    "    pass\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "76b6aa42-f19a-4d56-8ebe-a5b5aa8d6fe1",
   "metadata": {},
   "outputs": [],
   "source": [
    "first = f\"\"\"  \n",
    "<!DOCTYPE html>  \n",
    "<html lang=\"en\">  \n",
    "  \n",
    "<head>  \n",
    "  <meta charset=\"UTF-8\">  \n",
    "  <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no\">  \n",
    "  <title>Document</title>  \n",
    "</head>  \n",
    "<style>  \n",
    "  /* 全局样式 */  \n",
    "  * {{  \n",
    "    margin: 0;  \n",
    "    padding: 0;  \n",
    "  }}  \n",
    "  \n",
    "  h4 {{  \n",
    "    text-align: center;  \n",
    "  }}  \n",
    "  \n",
    "  em {{  \n",
    "    font-family: 'Franklin Gothic Medium', 'Arial Narrow', Arial, sans-serif;  \n",
    "    color: silver;  \n",
    "  }}  \n",
    "  \n",
    "  div > p {{  \n",
    "    width: 96%;  \n",
    "    padding: 2%;  \n",
    "  }}  \n",
    "  \n",
    "  a {{  \n",
    "    color: #1e90ff;  \n",
    "    text-decoration: none;  \n",
    "    transition: color 0.3s;  \n",
    "  }}  \n",
    "  \n",
    "  a:hover {{  \n",
    "    color: #ff6347;  \n",
    "  }}  \n",
    "  \n",
    "  p {{  \n",
    "    text-indent: 2em;  \n",
    "    text-align: justify;  \n",
    "  }}  \n",
    "</style>  \n",
    "  \n",
    "<body>  \n",
    "\"\"\".strip()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "62a8143e-6ba8-4c61-89bd-a1ebfbbb03d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "last = \"\"\"</body>  \n",
    "  \n",
    "</html>  \n",
    "\"\"\".strip()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "47385036-5d29-48a3-b356-e548fa33e735",
   "metadata": {},
   "outputs": [],
   "source": [
    "html_text = first+htmls+last\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ad70982c-4c6c-4f7f-9637-1e902c953c13",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e6638127-f9f4-42b1-80d0-06af706281e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "html_text = html_text.replace('\\n', '')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2546aaf9-5adb-4346-866e-26c3368545c1",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = {\n",
    "   \"touser\" : \"@all\",\n",
    "   \"toparty\" : \"PartyID1|PartyID2\",\n",
    "   \"totag\" : \"TagID1 | TagID2\",\n",
    "   \"msgtype\" : \"text\",\n",
    "   \"agentid\" : '1000002',\n",
    "   \"text\" : {\n",
    "       \"content\" : html_text\n",
    "   },\n",
    "   \"safe\":0,\n",
    "   \"enable_id_trans\": 0,\n",
    "   \"enable_duplicate_check\": 0,\n",
    "   \"duplicate_check_interval\": 1800\n",
    "}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ac8e9885-6a96-4b25-91cc-c549a74a5b6b",
   "metadata": {},
   "outputs": [],
   "source": [
    "from datetime import datetime\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e10314b3-afda-40d6-b51b-515001f1fa31",
   "metadata": {},
   "outputs": [],
   "source": [
    "title  = datetime.now().strftime(\"%Y年%m月%d日\") + '医疗行业资讯'\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d6ccc7f8-f974-4a3f-a816-2e233212a7b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = {\n",
    "   \"touser\" : \"chenweishi|SuBei|liqian9|YuanGuangJi\", # 切换正式环境必须修改！\n",
    "   \n",
    "   \"msgtype\" : \"mpnews\",\n",
    "   \"agentid\" : 1000002,\n",
    "   \"mpnews\" : {\n",
    "       \"articles\":[\n",
    "           {\n",
    "               \"title\": title, \n",
    "               \"thumb_media_id\": \"2tNI-yo4L7-cQmsgW2drOBeFz51E_R5vHa_mdIdU2pBdFUEPklOjTTM_SevJplbmb4khjjhmEVh_kZDALSuo8aQ\",\n",
    "               \"author\": \"大倩倩\",\n",
    "               \n",
    "               \"content\": html_text,\n",
    "               \"digest\": \" \"\n",
    "            }\n",
    "       ]\n",
    "   },\n",
    "   \"safe\":0,\n",
    "   \"enable_id_trans\": 0,\n",
    "   \"enable_duplicate_check\": 0,\n",
    "   \"duplicate_check_interval\": 1800\n",
    "}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a215a73c-43f9-42de-9f6d-5ff82ebce569",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d38b0dbe-ce99-4fa9-8495-8ff5c5c38108",
   "metadata": {},
   "outputs": [],
   "source": [
    "requests.post(\"https://qyapi.weixin.qq.com/cgi-bin/message/send?access_token=\"+get_token(), data= json.dumps(data), ).json()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "093906de-4536-46f0-99c9-fbce3571e235",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51a4bf22-0aca-4ab4-b3d4-eade9dabe69b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2545ee9e-0cc6-41e7-abe6-c096543fd196",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7f98e283-9437-4829-91f7-5a5cd950e2db",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "432b9f61-fa3d-4d25-82fc-4a0fbb1a201c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  },
  "widgets": {
   "application/vnd.jupyter.widget-state+json": {
    "state": {},
    "version_major": 2,
    "version_minor": 0
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
